Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
CABP4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Invitae Congenital Stationary Night Blindness Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 36 | 22 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Focused Inherited Retinal Disorders Panel PreventionGenetics, part of Exact Sciences United States | 36 | 31 |
|
Congenital Stationary Night Blindness Panel PreventionGenetics, part of Exact Sciences United States | 18 | 17 |
|
Leber Congenital Amaurosis Panel PreventionGenetics, part of Exact Sciences United States | 27 | 28 |
|
Cone-Rod Dystrophy via the CABP4 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 1 | 1 |
|
Leber Congential Amaurosis Panel (MitomeNGS) Baylor Genetics United States | 32 | 19 |
|
Baylor Genetics United States | 1 | 1 |
|
CABP4 Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 1 | 1 |
|
CABP4 Prenatal Sequence Analysis Baylor Genetics United States | 1 | 1 |
|
CABP4 Familial Mutation/Variant Analysis Baylor Genetics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.